Bank of New Hampshire’s GSK GSK Stock Holding History

Bank of New Hampshire’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$7.71K	Buy	+160	New	+$8.17K	﹤0.01%	469
2024 Q4	–	Sell	-46	Closed	-$1.88K	–	468
2024 Q3	$1.88K	Hold	46	–	–	﹤0.01%	442
2024 Q2	$1.77K	Hold	46	–	–	﹤0.01%	464
2024 Q1	$1.97K	Hold	46	–	–	﹤0.01%	461
2023 Q4	$1.71K	Sell	46 -58	-56%	-$2.08K	﹤0.01%	455
2023 Q3	$3.77K	Hold	104	–	–	﹤0.01%	451
2023 Q2	$3.71K	Hold	104	–	–	﹤0.01%	464
2023 Q1	$3.7K	Hold	104	–	–	﹤0.01%	463
2022 Q4	$4K	Hold	104	–	–	﹤0.01%	474
2022 Q3	$3K	Hold	104	–	–	﹤0.01%	489
2022 Q2	$6K	Hold	104	–	–	﹤0.01%	471
2022 Q1	$6K	Buy	+104	New	+$5.65K	﹤0.01%	482

Other funds holding GSK

KFP

Keystone Financial Planning Cleveland, Ohio $404M AUM 16.77% 1-Year Est. Return

Bonness Enterprises Washington, District of Columbia $307M AUM 22.88% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Parrish Capital Kennesaw, Georgia $103M AUM 35.11% 1-Year Est. Return

IRC

Investors Research Corp Atlanta, Georgia $569M AUM 15.41% 1-Year Est. Return

BCM

Boltwood Capital Management Walnut Creek, California $443M AUM 17.72% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

CPBTD

Central Pacific Bank - Trust Division Honolulu, Hawaii $952M AUM 25.15% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Rockland Trust Hanover, Massachusetts $2.61B AUM 14.26% 1-Year Est. Return

Bank of New Hampshire's GSK Position: Q3 2026 in Review

Bank of New Hampshire opened a new position in GSK (GSK) in Q3 2026: 160 shares worth $7.71K. The stake represents ﹤0.01% of the portfolio and ranks #469 among its holdings. This is a return to the name: Bank of New Hampshire previously reported a position in GSK as recently as Q3 2024.

Bank of New Hampshire first reported a position in GSK in Q1 2022 and has held it in 12 quarters since. 33 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

Bank of New Hampshire held 160 shares of GSK worth $7.71K as of Q3 2026.
GSK was a new Bank of New Hampshire position in Q3 2026.
GSK made up ﹤0.01% of Bank of New Hampshire's portfolio in Q3 2026, its #469 holding.
Bank of New Hampshire first reported a position in GSK in Q1 2022 and has held it in 12 quarters since.
33 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on Bank of New Hampshire's 13F filing for Q3 2026, filed 6 Oct 2026.